139 related articles for article (PubMed ID: 9202205)
1. Alternative signaling mechanism of leukemia inhibitory factor responsiveness in a differentiating embryonal carcinoma cell.
Takeda T; Kurachi H; Yamamoto T; Homma H; Adachi K; Morishige K; Miyake A; Murata Y
Endocrinology; 1997 Jul; 138(7):2689-96. PubMed ID: 9202205
[TBL] [Abstract][Full Text] [Related]
2. The role of the growth hormone (GH) receptor and JAK1 and JAK2 kinases in the activation of Stats 1, 3, and 5 by GH.
Smit LS; Meyer DJ; Billestrup N; Norstedt G; Schwartz J; Carter-Su C
Mol Endocrinol; 1996 May; 10(5):519-33. PubMed ID: 8732683
[TBL] [Abstract][Full Text] [Related]
3. Inhibitory roles for SHP-1 and SOCS-3 following pituitary proopiomelanocortin induction by leukemia inhibitory factor.
Bousquet C; Susini C; Melmed S
J Clin Invest; 1999 Nov; 104(9):1277-85. PubMed ID: 10545526
[TBL] [Abstract][Full Text] [Related]
4. Induction of differentiation by IL-6-type cytokines is impaired in myeloid leukaemia cells unable to activate Stat5a.
Piekorz RP; Hocke GM
Cytokine; 1997 Sep; 9(9):639-49. PubMed ID: 9325012
[TBL] [Abstract][Full Text] [Related]
5. The Ras/Raf/MEK/extracellular signal-regulated kinase pathway induces autocrine-paracrine growth inhibition via the leukemia inhibitory factor/JAK/STAT pathway.
Park JI; Strock CJ; Ball DW; Nelkin BD
Mol Cell Biol; 2003 Jan; 23(2):543-54. PubMed ID: 12509453
[TBL] [Abstract][Full Text] [Related]
6. Activation of Jak-Stat and MAPK2 pathways by oncostatin M leads to growth inhibition of human glioma cells.
Halfter H; Friedrich M; Postert C; Ringelstein EB; Stögbauer F
Mol Cell Biol Res Commun; 1999 May; 1(2):109-16. PubMed ID: 10356359
[TBL] [Abstract][Full Text] [Related]
7. Activation of JAK-STAT and MAP kinases by leukemia inhibitory factor through gp130 in cardiac myocytes.
Kunisada K; Hirota H; Fujio Y; Matsui H; Tani Y; Yamauchi-Takihara K; Kishimoto T
Circulation; 1996 Nov; 94(10):2626-32. PubMed ID: 8921810
[TBL] [Abstract][Full Text] [Related]
8. Leukemia inhibitory factor-dependent transcriptional activation in embryonic stem cells.
Boeuf H; Hauss C; Graeve FD; Baran N; Kedinger C
J Cell Biol; 1997 Sep; 138(6):1207-17. PubMed ID: 9298977
[TBL] [Abstract][Full Text] [Related]
9. LIF-induced STAT3 signaling in murine versus human embryonal carcinoma (EC) cells.
Schuringa JJ; van der Schaaf S; Vellenga E; Eggen BJ; Kruijer W
Exp Cell Res; 2002 Mar; 274(1):119-29. PubMed ID: 11855863
[TBL] [Abstract][Full Text] [Related]
10. Cytokine signal transduction in P19 embryonal carcinoma cells: regulation of Stat3-mediated transactivation occurs independently of p21ras-Erk signaling.
van Puijenbroek AA; van der Saag PT; Coffer PJ
Exp Cell Res; 1999 Sep; 251(2):465-76. PubMed ID: 10471331
[TBL] [Abstract][Full Text] [Related]
11. Protein-tyrosine phosphatase PTPepsilon C inhibits Jak-STAT signaling and differentiation induced by interleukin-6 and leukemia inhibitory factor in M1 leukemia cells.
Tanuma N; Nakamura K; Shima H; Kikuchi K
J Biol Chem; 2000 Sep; 275(36):28216-21. PubMed ID: 10859312
[TBL] [Abstract][Full Text] [Related]
12. Leukemia inhibitory factor, a potent cardiac hypertrophic cytokine, activates the JAK/STAT pathway in rat cardiomyocytes.
Kodama H; Fukuda K; Pan J; Makino S; Baba A; Hori S; Ogawa S
Circ Res; 1997 Nov; 81(5):656-63. PubMed ID: 9351438
[TBL] [Abstract][Full Text] [Related]
13. Activation of the Janus kinase/STAT (signal transducer and activator of transcription) signal transduction pathway by interleukin-6-type cytokines promotes osteoblast differentiation.
Bellido T; Borba VZ; Roberson P; Manolagas SC
Endocrinology; 1997 Sep; 138(9):3666-76. PubMed ID: 9275051
[TBL] [Abstract][Full Text] [Related]
14. Signals through gp130 upregulate bcl-x gene expression via STAT1-binding cis-element in cardiac myocytes.
Fujio Y; Kunisada K; Hirota H; Yamauchi-Takihara K; Kishimoto T
J Clin Invest; 1997 Jun; 99(12):2898-905. PubMed ID: 9185513
[TBL] [Abstract][Full Text] [Related]
15. Leukemia inhibitory factor as a mediator of JAK/STAT activation in murine osteoblasts.
Lowe C; Gillespie GA; Pike JW
J Bone Miner Res; 1995 Nov; 10(11):1644-50. PubMed ID: 8592940
[TBL] [Abstract][Full Text] [Related]
16. Contributions of leukemia inhibitory factor receptor and oncostatin M receptor to signal transduction in heterodimeric complexes with glycoprotein 130.
Hermanns HM; Radtke S; Haan C; Schmitz-Van de Leur H; Tavernier J; Heinrich PC; Behrmann I
J Immunol; 1999 Dec; 163(12):6651-8. PubMed ID: 10586060
[TBL] [Abstract][Full Text] [Related]
17. STAT3 activation is a critical step in gp130-mediated terminal differentiation and growth arrest of a myeloid cell line.
Minami M; Inoue M; Wei S; Takeda K; Matsumoto M; Kishimoto T; Akira S
Proc Natl Acad Sci U S A; 1996 Apr; 93(9):3963-6. PubMed ID: 8632998
[TBL] [Abstract][Full Text] [Related]
18. CIS3 and JAB have different regulatory roles in interleukin-6 mediated differentiation and STAT3 activation in M1 leukemia cells.
Suzuki R; Sakamoto H; Yasukawa H; Masuhara M; Wakioka T; Sasaki A; Yuge K; Komiya S; Inoue A; Yoshimura A
Oncogene; 1998 Oct; 17(17):2271-8. PubMed ID: 9811457
[TBL] [Abstract][Full Text] [Related]
19. Crosstalk between the interleukin-6 (IL-6)-JAK-STAT and the glucocorticoid-nuclear receptor pathway: synergistic activation of IL-6 response element by IL-6 and glucocorticoid.
Takeda T; Kurachi H; Yamamoto T; Nishio Y; Nakatsuji Y; Morishige Ki; Miyake A; Murata Y
J Endocrinol; 1998 Nov; 159(2):323-30. PubMed ID: 9795374
[TBL] [Abstract][Full Text] [Related]
20. Activation of phosphatidylinositol 3-kinase through glycoprotein 130 induces protein kinase B and p70 S6 kinase phosphorylation in cardiac myocytes.
Oh H; Fujio Y; Kunisada K; Hirota H; Matsui H; Kishimoto T; Yamauchi-Takihara K
J Biol Chem; 1998 Apr; 273(16):9703-10. PubMed ID: 9545305
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]